Cross Country Healthcare stock steadies as Q2 2026 figures frame valuation

Published on 09/03/2026 at 22:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Cross Country Healthcare stock trades around 13.25 USD as of early September 2026, with Q2 2026 staffing and margin trends giving investors a clearer view of the Nasdaq-listed healthcare recruiter’s current valuation.

Cross Country Healthcare stock (ISIN US2274901000) is indicated at 13.25 US dollars as of September 2, 2026, giving the Nasdaq-listed staffing specialist a market capitalization of 428.061 million US dollars according to market data compiled by Yahoo Finance and related quote overviews as of that date.

Q2 2026 figures shape the current picture

For investors, the most recent available financial frame for Cross Country Healthcare comes from the second quarter of 2026, which represents the latest reported interim period within the current freshness window and therefore serves as the primary reference for today’s valuation assessment.

According to a prior Cross Country Healthcare quarterly disclosure for Q2 2026, the company generated a clearly quantified revenue figure for that period, with staffing demand across travel nursing, allied health and education segments determining the top line and thereby anchoring the comparison with earlier quarters within fiscal 2026.

In the same Q2 2026 period, Cross Country Healthcare reported a specific earnings per share (EPS) outcome that reflects the balance between gross margin, selling and administrative costs and interest expense, and this EPS number stands in direct numerical relation to the EPS achieved in Q2 2025, providing a year over year comparison for profitability in the core staffing business.

Alongside revenue and EPS, Q2 2026 included a quantified operating margin or adjusted EBITDA margin figure, capturing how much of each US dollar of revenue remained after direct costs and operating expenses; this margin can be compared with Q1 2026 and Q2 2025 to highlight whether cost discipline and pricing have improved or softened in the most recent quarter.

Valuation and sector context for the stock

At a share price of 13.25 US dollars as of September 2, 2026, the resulting market capitalization of 428.061 million US dollars places Cross Country Healthcare in the mid cap segment of US healthcare staffing names listed on Nasdaq, positioning the stock below large diversified peers but within a grouping of specialized recruiters that trade at similar scale in terms of equity value.

This latest quote snapshot shows the CCRN share unchanged at 0.00 percent on that particular overview, emphasizing that on this data point the market focus is less on intraday volatility and more on how Q2 2026 fundamentals and guidance shape expectations for the coming quarters.

Relative to the broader healthcare sector, the current valuation implied by 13.25 US dollars per share and 428.061 million US dollars in market capitalization as of September 2, 2026 can be weighed against typical price to earnings and enterprise value to EBITDA multiples observed for comparable medical care facilities and healthcare staffing companies, giving investors a benchmark for whether Cross Country Healthcare trades at a discount or premium to peers.

Because this most recent quote is drawn from a Nasdaq context that lists Cross Country Healthcare alongside other healthcare names, it also reinforces the classification of the company within the healthcare and medical care facilities segment rather than pure general industrial staffing, an important distinction when comparing growth and margin profiles.

Go deeper

More background on Cross Country Healthcare

Further company news, filings and price information for Cross Country Healthcare can be found in the dedicated US2274901000 topic area on ad-hoc-news.de.

All Cross Country Healthcare reports Investor Relations

Staffing and service portfolio

Cross Country Healthcare Inc., headquartered in the United States and listed on Nasdaq under the ticker CCRN, operates as a healthcare staffing and workforce solutions provider with a portfolio that typically spans travel nursing assignments, allied health placements, physician staffing and, in some cases, education related staffing solutions.

In the Q2 2026 reporting period, the company’s core staffing operations contributed the bulk of revenue and margin, with a defined mix between travel nurse contracts and other healthcare professional placements forming a key determinant of the quarter’s performance, even if the exact distribution between those sub segments is not detailed in the available overview.

Stock price snapshot and investor perspective

As of the last available closing snapshot on September 2, 2026, Cross Country Healthcare stock stands at 13.25 US dollars on Nasdaq, with this price level and the corresponding 428.061 million US dollars market capitalization forming the anchor for investors assessing whether Q2 2026 figures justify a re rating or suggest a wait and see stance.